Your Most Trusted Partner Since 1946
logo
Facebook Instagram LinkedIn

Patience, Perseverance & Visionary Growth Strategy

Inspired By Value, Driven By Vision

Company Profile

About Us

About us

Novo Medi Sciences, established in 1946, has been a trusted name in the Indian pharmaceutical industry, specializing in vaccines, critical care medicines, nutraceuticals, and more. With over 80 years of experience, the company is committed to providing high-quality, affordable healthcare solutions, ensuring accessibility to life-saving medicines across the globe.

80+ Years Excellence 80+ Years Excellence

Over 80 years of experience in manufacturing, R&D, international business, domestic marketing, and end-to-end distribution across India of specialty pharmaceutical products.

Our Achievement Our Achievement

Achievements include introducing and successfully marketing various existing as well as new molecules in India, making them multi-million brands within record time in vaccines, cardiovascular, immunological, oncology, fertility hormones, neurology and several injectable and antibiotics. Established more than 400 brands, out of which 20 held number one position in India.

Global Presence Global Presence

Well established with 26 branch offices & more than 1000 distribution points across India.

Expertise Background

Our Speciality

Pioneering Excellence

Pioneering Excellence

Introduced more than 100 molecules for the first time in India.

Proven Expertise

Proven Expertise

A notable history in brand building, strategic marketing, and ethical promotions across key therapeutic segments.

Strong Relationships

Strong Relationships

Long-standing relationships with the medical fraternity across India

Extensive Distribution

Extensive Distribution

One of the largest and most extensive distribution network nationwide.

In-house Experts

In-house Experts

A dedicated in-house medical and technical team, driving product innovation.

Mission & Vision

Mission Vision

Our Mission

Our mission is to deliver high-quality, globally compliant, preventive vaccines and critical care medicines that reach the last mile. As innovators in next-generation medicine, we seek to pre-emptively prevent diseases and resolve emerging healthcare challenges with safe, scientifically advanced and efficacious solutions. Through continuous innovation at the edge of the biopharma industry, we seek to augment public health and enhance lives across the world.

Our Vision

To strengthen our legacy and deliver innovative, research-based, clinically proven safe and effective products that help in combating diseases in India and across the world. Through continuous advancements, global collaboration & pioneering efforts, we aim to set new benchmarks in the biopharmaceutical industry, ensuring a healthier and sustainable future.

Achievement & Awards

Milestones that inspire trust.

Novo Medi Sciences has been consistently recognized for its excellence in pharmaceutical innovation, manufacturing quality, and healthcare impact.

From national industry awards to breakthrough product recognitions, these milestones reflect decades of commitment to quality, research, and patient-focused solutions.

Late Mr. R. C. Bhagat – Lifetime Achievement Award

Late Mr. R. C. Bhagat – Lifetime Achievement Award

As a great lover of humanity, Shri R. C. Bhagat cherished the ideal that Medicines were for the people and not for profits. He was honored with the Lifetime Award in 2016. He was always leading from the front, helping as much he can.

Leading SMEs of India 2025.

Leading SMEs of India 2025.

Novo Medi Sciences Pvt. Ltd. is proud to be recognized by Dun & Bradstreet as one of the Leading SMEs of India 2025. This accolade reflects our dedication to quality, innovation, and ethical growth.

The Maharashtra State Best Employer Brand Awards

The Maharashtra State Best Employer Brand Awards

Novo Medi Sciences is honored as Maharashtra State Best Employer Brand Award, recognizing our people-first culture, progressive workplace practices, and commitment to employee growth and well-being.

Accreditation by IAP & ACVIP for Varicella Vaccine, Nexipox, in 2018 Accreditation by IAP & ACVIP for Varicella Vaccine, Nexipox, in 2018

Accreditation by IAP & ACVIP for Varicella Vaccine, Nexipox, in 2018

NEXIPOX was recognized by the ACVIP committee of IAP in 2018 based on proof that it is superior to other varicella vaccines in terms of higher and better effectiveness.

Emerging Company of the Year 2016

Emerging Company of the Year 2016

NOVO was recognized as One of the Fastest Growing Pharma Company in 2016 for its Varicella Vaccine, Nexipox which was launched in 2015. Nexipox was Ranked No. 2 All India within 1 year of its launch. More than 0.25 Million babies were vaccinated with Nexipox and NOVO is recognized as the ‘’Emerging Company of the Year 2016’’

Excellence in Economic Development Award 2010

Excellence in Economic Development Award 2010

Excellence in Economic Development Award function, at the 23rd Indian Achievers Summit on 22nd April 2010 at India Habitat Centre, New Delhi. Woman Entrepreneur Award 2010 was given to Ms. Anju Gupta Kaudanya – Managing Director. The awards are given to honor organizations and individuals that have brought positive change in urban, suburban and rural communities.

Assocham Awards 2009

Assocham Awards 2009

NOVO Management bagged prestigious ‘ASSOCHAM AWARDS’ in the category of India’s Fastest Growing Pharmaceutical Company in the year 2009.

NOVO Management bags three pharma leadership awards 2009

NOVO Management bags three pharma leadership awards 2009

Management witnessed dramatic growth and through their aggressive positioning and strategy the Organization won many laurels and awards.

The IDMA “Quality Excellence Award 2009

The IDMA “Quality Excellence Award 2009

Indian Drug Manufacturer's Association confers NOVO Management wins the "Quality Excellence Award 2009" for formulations unit - turnover above 100 crores.

Gold Standard Manufacturing Sites Gold Standard Manufacturing Sites

Gold Standard Manufacturing Sites

Set up of 5 modern manufacturing sites compliant with USFDA, MHRA at Uttarakhand in India under the guidance of NOVO Management.